More likely in my mind to be a partnership and further funds injection from that type of transaction.
While I think we're extremely busy conducting/cooperating on these 7 Clinical trials for paxalisib and finalising the Cantrixil phase 1 Clinical trial data, it may also be that we are going to venture on another molecule, perhaps a far larger commercial and impactful medical need!!?
@rikki you may want to add your own thoughts against your good question. When I heard that I was truly impressed on the level of confidence JG projected! I had been thinking that Kazia would not just become a company that's bought out to end up as another entity, hence my question to him recently on taking a partnering level commercial agreement for paxalisib for the future...
So many chances of success now across many forms of cancer for only 2 molecules under our guidance. I think and hope we will do another GDC-0084 in the near future.
- Forums
- ASX - By Stock
- KZA
- "We reserve the right to surprise"
"We reserve the right to surprise", page-7
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online